Posted in Uncategorized US F.D.A. Approves Ivacaftor lynn posted on 31 January 2012 No Comment Bravo to Vertex for bringing this to market. Molecules to address the genetic basis of a disease are incredibly expensive to develop and market. Even though this only addresses one of the mutated Read More